chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 60.0
Sex: F
Vaccine: FLU3
Symptoms: Joint range of motion decreased, Musculoskeletal pain
Clinical narrative: The case report was received from a(n) Health Professional and concerns a(n) 60 years old female patient. Weight: not provided, Height: not provided. Concurrent medical condition(s), medical and drug history: The patient has a medical history of Post-shingles in Jun-2015. For concomitant medication and therapy dates refer to the appropriate report sections. Suspect drug(s), timing and conditions surrounding the onset of reaction(s)/events(s): The patient received AFLURIA for indication no reported on 12-Oct-2015- unknown stop date, Batch no: U58908, Route of administration: Unknown, Dose: 0.5 ml. Additional suspect drug(s): No additional drugs suspected. Reaction(s)/event(s) and outcome: On 12-Oct-2015, 1 day after starting/treatment with AFLURIA the patient experienced shoulder pain (non serious, outcome: Unknown), Limited range of shoulder movement (non serious, outcome: Unknown). Event treatment: ibuprofen (600 mg, twice daily) and gabapentin (100 mg at bedtime). For relevant test results see appropriate report section. Reporter's assessment: The health authority assessed the events as non-serious.
Age: 54.0
Sex: F
Vaccine: FLU3, PPV, TDAP
Symptoms: Pruritus, Skin irritation, Skin ulcer, Wound
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 54 year old female patient. The patient has a medical history of heart disease and Asthma. The patient had no illness at time of vaccination. The patient reported no fever and was feeling well. Concomitant medications at the time of vaccination are unknown. The patient received AFLURIA on 08-Oct-2015 - unknown stop date, Batch no: U58808, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Left arm (LA). PNEUMOVAX (batch number: L024129), Indication: not provided, Site: Left arm (LA) and BOOSTRIX (batch number: 94375), Indications: not provided, Site: Right arm (RA). Both AFLURIA and PNEUMOVAX were administered to left arm (medication error not explicitly reported). On 06-Nov-2015, 4 weeks 1 day after starting / treatment with AFLURIA the patient experienced Sore on her right arm [that appeared to be irritated], [Sore on her] right arm that appeared to be irritated, Patient reported [scratching the sore which resulted in an ] open wound, Itchy on her right arm. Reporter's assessment: Non serious. VAERS: 608097. Case correction (11-Mar-2016): AE 1 re-coded to skin lesions, company causality for AE 3 corrected to possible.
Age: 43.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site reaction, Injection site scab
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 43 year old male patient. The patient had no medical history and no illness at the time of vaccination. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA (dose number: 2) on 13-Oct-2015 - unknown stop date, Batch no: U58407, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Left arm (LA). No additional drugs suspected. On 20-Oct-2015, 1 week 1 day after starting treatment with AFLURIA the patient experienced Injection site developed into a scab, Injection site redness, Injection site reaction. He cleaned it with alcohol and scab went away after 10 days. Reporter's assessment: Non serious. VAERS ID: 608270.
Age: 45.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Pain
Clinical narrative: This health authority case was initially received on 16-Dec-2015. Follow up information received on 11-Mar-2016. The case report was received from a Health Professional and concerns a 45 years old female patient. Weight: not provided, Height: not provided. The patient has a medical history of Nuts, Seed allergy and E-mycin (allergy). The following drug history information was reported: E-mycin (Indication: -, Reaction: Allergy). For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 24-Oct-2015 - unknown stop date, Batch no: U57407, Route of administration: Intramuscular, Dose: 0.5 ml, Site: left arm. No additional drugs suspected. On 28-Oct-2015, 5 days after starting / treatment with AFLURIA the patient experienced Pain, soreness at injection site. For relevant test results see appropriate report section. Reporter's assessment: non-serious. VAERS ID: 608399.
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Muscle disorder, Neck pain, Pain, Pain in extremity
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a(n) Health Professional and concerns a (n) 57 year old female patient. The patient had no illness at the time of vaccination. The patient received AFLURIA on 22-Oct-2015 - unknown stop date, Batch no: U50609, route of administration: Intramuscular, Dose: 0.5 ml, Site: Left arm (LA). No additional drugs suspected. On 26-Oct-2015 5 days after starting treatment with AFLURIA the patient experienced pain in her left side, pain radiates from her neck, pain radiates to her arm, seems to be a muscle problem. Pain relievers do not help. Ice is the only thing that reduces the pain. Reporter's assessment: Non serious.
Age: 80.0
Sex: F
Vaccine: FLU3
Symptoms: Chills, Cough, Dysphagia, Headache, Injection site bruising
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 80 year old female patient. At the time of the event the patient concomitantly suffered from Bladder infection. The patient has a material history of 'CIPRO Thiomersal'. At the age of -65 years, the patient experienced an adverse event following prior vaccination with 'Pneumo (no brand name)'. The patient received AFLURIA on 26-Oct-2015 - unknown stop date, Batch no: U50809, Route of administration: 'SYR', Dose: 0.5 ml, Site: Right arm (RA). No additional drugs suspected. On 28-Oct-2015, 3 days after starting treatment with AFLURIA the patient experienced Difficulty swallowing, Coughing, Sneezing, Running nose, Coughing up phlegm, Injection site black bruise 1 1/2" x 1 1/2" upper right arm, Headache, Fever (1 degree), Chills. Reporter's assessment: Non serious. VAERS ID: 608444.
Age: 80.0
Sex: F
Vaccine: FLU3
Symptoms: Productive cough, Pyrexia, Rhinorrhoea, Sneezing
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 80 year old female patient. At the time of the event the patient concomitantly suffered from Bladder infection. The patient has a material history of 'CIPRO Thiomersal'. At the age of -65 years, the patient experienced an adverse event following prior vaccination with 'Pneumo (no brand name)'. The patient received AFLURIA on 26-Oct-2015 - unknown stop date, Batch no: U50809, Route of administration: 'SYR', Dose: 0.5 ml, Site: Right arm (RA). No additional drugs suspected. On 28-Oct-2015, 3 days after starting treatment with AFLURIA the patient experienced Difficulty swallowing, Coughing, Sneezing, Running nose, Coughing up phlegm, Injection site black bruise 1 1/2" x 1 1/2" upper right arm, Headache, Fever (1 degree), Chills. Reporter's assessment: Non serious. VAERS ID: 608444.
Age: 68.0
Sex: F
Vaccine: FLU3, PNC13, TDAP
Symptoms: Chills, Injection site erythema, Injection site swelling, Pruritus, Pyrexia
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a(n) Health Professional and concerns a(n) 68 year old female patient. The patient has a medical history of Hypothyroidism, Overactive bladder, Dyslipidemia, and allergy to PHENERGAN. The patient had no illness at the time of vaccination. The patient received AFLURIA (dose number: 2) on 02-Nov-2015, Batch no: U55306, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Left arm (LA). Additional suspect drug(s): PREVNAR 13, Batch no: M06898, Route: Intramuscular, Site: Right arm (RA) and BOOSTRIX, Batch no: XZ444, Route: Intramuscular, Site: Right arm (RA). On 03-Nov-2015, 2 days after starting treatment with AFLURIA the patient experienced fevers, chills, redness around the injection site, swelling around the injection site, and localized itching on right arm. Lab data: None. Reporter's assessment: Non serious.
Age: 63.0
Sex: F
Vaccine: FLU3
Symptoms: Chills, Dizziness, Headache, Malaise, Pain
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 63 year old female patient. The patient has a medical history of asthma and glaucoma. The patient had no illness at the time of vaccination. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 07-Nov-2015 - unknown stop date, Batch no: U59308, Route of administration: 'SYR', dose: 0.5 ml, Site: Left arm (LA). No additional drugs suspected. On 07-Nov-2015, at 3:30 the patent experienced dizziness, headache. At 5:00 chills. At 5:30 body aches. At 6:30 overall malaise. The patient took acetaminophen around 13:00 because of feeling headache and body aches. Took acetaminophen again at 18:00 and every 6 hours after that through 08-Nov-2015. Reporter's assessment: Non serious. VAERS ID: 608544.
Age: 68.0
Sex: F
Vaccine: FLU3, PNC13
Symptoms: Inflammation, Insomnia, Pain in extremity, Peripheral swelling, Pruritus
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 68 year old female patient. The patient had no medical history and no illness at the time of vaccination. The patient received AFLURIA on 28-Oct-2015 - unknown stop date, Batch no: U59208, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Left arm (LA). PREVNAR 13, Batch no: L99275, Route: Intramuscular, Indication: not provided, Site: Left arm (LA). AFLURIA and PREVNAR administered to the same arm (medication error not explicitly reported). On 08-Nov-2015, 1 week 5 days after starting / treatment with AFLURIA the patient experienced Difficulty sleeping, Arm noticeably swollen / Left arm swelling, Left arm pain, Inflamm, Warm to touch, Itching at elbow. Reporter's assessment: Non serious. VAERS ID: 608559.
Age: 68.0
Sex: F
Vaccine: FLU3, PNC13
Symptoms: Skin warm
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 68 year old female patient. The patient had no medical history and no illness at the time of vaccination. The patient received AFLURIA on 28-Oct-2015 - unknown stop date, Batch no: U59208, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Left arm (LA). PREVNAR 13, Batch no: L99275, Route: Intramuscular, Indication: not provided, Site: Left arm (LA). AFLURIA and PREVNAR administered to the same arm (medication error not explicitly reported). On 08-Nov-2015, 1 week 5 days after starting / treatment with AFLURIA the patient experienced Difficulty sleeping, Arm noticeably swollen / Left arm swelling, Left arm pain, Inflamm, Warm to touch, Itching at elbow. Reporter's assessment: Non serious. VAERS ID: 608559.
Age: 18.0
Sex: F
Vaccine: FLU3
Symptoms: Body temperature increased, Disorientation, Dizziness
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 18 year old female patient. The patient had no medical history and had no illness at the time of vaccination. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 21-Oct-2015 - unknown stop date, Batch no: U58508, Route of administration: Unknown, Dose: 0.5 ml, Site: Left arm (LA). No additional drugs suspected. On an unknown date, 3 hours after starting treatment with AFLURIA (after which she engaged in strenuous exercise via a dance class) the patient experienced Began to feel faint, Began to feel disoriented, HR at 120 bpm, Temperature was measured at 103 degrees F, Body temperature increased. Reporter's assessment: Non serious. The health authority reported the symptom: body temperature increased. VAERS ID: 608613. Follow-up information received 04-Mar-2016. The patient received the AFLURIA vaccination on 26-Oct-2015. Case evaluation and comment: No change to assessment.
Age: 51.0
Sex: F
Vaccine: FLU3
Symptoms: Blister, Injection site pain, Injection site vesicles, Neuralgia, Pain in extremity
Clinical narrative: This health authority case was received from a(n) Health Professional and concerns a(n) 51 year old female patient. The patient had no medical history and no illness at the time of vaccination. For concomitant medications and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 04-Nov-2025 - unknown stop date, Batch no: not provided, Route of administration: Intramuscular, site: Left arm (LA). No additional drugs suspected. On 06-Nov-2015, 3 days after starting treatment with AFLURIA the patient experienced painful nerve all up and down my left arm, burning feeling all up and down my left arm, blisters all up and down my left arm, pain all up and down my left arm/ Surges of pain all up and down my left arm, injection site vesicles, injection site pain. The health authority reported the symptoms: injection site vesicles, injection site pain.
Age: 73.0
Sex: M
Vaccine: FLU3
Symptoms: Electrocardiogram normal, Oropharyngeal pain, Throat tightness
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a(n) Health Professional and concerns a(n) 73 year old male patient. The patient has a medical history of Multiple sclerosis, other specified malignant neoplasm of skin of other and unspecified parts of face, tobacco use, Hypercholesterolemia, Barrett's esophagus, Hypertension, GERD and Dyslipidemia. The following drug history information was reported: MUCINEX, syncope, MUCINEX, dizziness, and oxycodone, very dizzy. The patient received AFLURIA on 09-Nov-2015, Batch no: U50509, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Left arm (LA). No additional drugs suspected. On 09-Nov-2015 20:20, 6 hours 18 mins after starting treatment with AFLURIA the patient experienced tightness in throat, and pain in throat. At 20:45 pain was gone, lungs clear, EKG normal sinus rhythm, no block no ST changes. No angioedema. Can swallow without difficulty. No rash noted. Event treatment: Prescribed hydroxyzine 25 mg q 4 h x 2 days. Reporter's assessment: Non serious.
Age: 36.0
Sex: F
Vaccine: FLU3
Symptoms: Chest discomfort, Chest pain, Cough, Eye discharge, Myalgia
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 36 year old female patient. The patient had a medical history of 'thyroid' and had no illness at the time of vaccination. For concomitant medication and therapy dates refer to the appropriate report sections. Concomitant medication also includes 'PLEXUS TRIPLEX (probiotics and blood sugar regulation)'. The patient received AFLURIA on 10-Nov-2015 - unknown stop date, Batch no: 12149221A, Route of administration: Intramuscular, Site: Left arm (LA). No additional drugs suspected. On 10-Nov-2015, 1 day after starting / treatment with AFLURIA the patient experienced Swollen throat, Tightness in chest, Pain in chest, Drainage from eyes, Body aches, Non-productive cough, Rash on back of hands, Painful throat, Muscle aches. Reporter's assessment: Non serious. VAERS ID: 608979. Case correction (11-Mar-2016): AE 6 re-coded to 'cough non-productive', assessment for AE 8 corrected to unlisted.
Age: 36.0
Sex: F
Vaccine: FLU3
Symptoms: Oropharyngeal pain, Pain, Pharyngeal oedema, Rash
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 36 year old female patient. The patient had a medical history of 'thyroid' and had no illness at the time of vaccination. For concomitant medication and therapy dates refer to the appropriate report sections. Concomitant medication also includes 'PLEXUS TRIPLEX (probiotics and blood sugar regulation)'. The patient received AFLURIA on 10-Nov-2015 - unknown stop date, Batch no: 12149221A, Route of administration: Intramuscular, Site: Left arm (LA). No additional drugs suspected. On 10-Nov-2015, 1 day after starting / treatment with AFLURIA the patient experienced Swollen throat, Tightness in chest, Pain in chest, Drainage from eyes, Body aches, Non-productive cough, Rash on back of hands, Painful throat, Muscle aches. Reporter's assessment: Non serious. VAERS ID: 608979. Case correction (11-Mar-2016): AE 6 re-coded to 'cough non-productive', assessment for AE 8 corrected to unlisted.
Age: 60.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Pain, Pain in extremity
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a non Health Professional and concerns a (n) 60 year old male patient. The patient has a medical history of smoker (quite in June of 2015) and Emphysema. The patient had no concomitant medications and reported no illness at the time of vaccination. The patient received AFLURIA on 08-Nov-2015 - unknown stop date, Batch no: U56807, route of administration: Intramuscular, Dose: 0.5 ml, site: right arm (RA). PNEUMOVAX, Batch no: L024129, Route: intramuscular, indication: not provided, site: Left arm (LA). On 08-Nov-2015, 1 day after starting  treatment with AFLURIA the patient experienced sharp, shooting pain. The pain was located in the arm that the pneumococcal vaccine was administered (left arm), pain. Reporter's assessment: Non serious. The health authority reported the symptom: pain.
Age: 54.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a(n) Health Professional and concerns a(n) 54 year old female patient. The patient has a medical history of 'penicillin, CECLOR, sulfur'. The patient had no illness at the time of vaccination. The patient received AFLURIA (dose number: 1) on 10-Nov-2015, Batch no: U58808, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Left arm (LA). No additional drugs suspected. On 11-Nov-2015, 2 days after starting treatment with AFLURIA the patient experienced Arm is hot around injection site area, Arm is swollen around injection site area, and Arm is red around injection site area. Reporter's assessment: Non serious.
Age: 56.0
Sex: M
Vaccine: FLU3
Symptoms: Contusion, Local swelling
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a(n) Health Professional and concerns a(n) 56 year old male patient. The patient had no medical history and no illness at the time of vaccination. The patient received AFLURIA on 01-Nov-2015 - unknown stop date, Batch no: U50609, route of administration: Intramuscular, Dose: 0.5 ml, Site: left arm (LA).  No additional drugs suspected. On 12-Nov-2015, after starting / treatment with AFLURIA the patient experienced area was still swollen, area was still bruised. Reporter's assessment: non serious.
Age: 58.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Limb discomfort, Local swelling, Musculoskeletal discomfort, Peripheral swelling
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a(n) Health Professional and concerns a(n) 58 years old female patient. The patient has a medical history of Hypertension. The patient had no illness at the time of vaccination. The patient received AFLURIA (dose number: 3) on 27-Oct-2015, Batch no: U59108, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Right arm (RA). No additional drugs suspected. On 27-Oct-2015, 1 day after starting treatment with AFLURIA the patient experienced swelling in neck, swelling in arm, swelling in shoulder, discomfort in arm, discomfort in shoulder/neck, and redness in arm/shoulder/neck. Reporter's assessment: Non serious.
Age: 58.0
Sex: F
Vaccine: FLU3
Symptoms: Swelling
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a(n) Health Professional and concerns a(n) 58 years old female patient. The patient has a medical history of Hypertension. The patient had no illness at the time of vaccination. The patient received AFLURIA (dose number: 3) on 27-Oct-2015, Batch no: U59108, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Right arm (RA). No additional drugs suspected. On 27-Oct-2015, 1 day after starting treatment with AFLURIA the patient experienced swelling in neck, swelling in arm, swelling in shoulder, discomfort in arm, discomfort in shoulder/neck, and redness in arm/shoulder/neck. Reporter's assessment: Non serious.
Age: 43.0
Sex: F
Vaccine: FLU3
Symptoms: Body temperature increased, Cough, Erythema, Feeling hot, Pruritus
Clinical narrative: This health authority report was received from a Health Professional and concerns a 43 years old female patient. Weight: not provided, Height: not provided. The patient has a medical history of Mild asthma, Seasonal allergies, Migraines, Cervical neck disk herniation (from auto accident), Vitamin D deficiency, WPW (Wolff-Parkinson White syndrome) (with ablation), Mitral valve prolapse, Allergies to sulfa, COMPAZINE and Allergy to bee stings. Sulfa (Indication: -, Reaction: allergy) and COMPAZINE (Indication: -, Reaction: allergy). The patient had no current illness. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 06-Nov-2015 - unknown stop date, Batch no: U55606, Route of administration: Intradermal (medication error not explicitly reported), Dose: 0.5 ml. No additional drugs suspected. On 06-Nov-2015 at 7:15am, the patient felt hot, and her skin on her chest and neck were red. The patient was a nurse and was in a patient's room in an isolation gown. She thought she was hot and the patient noticed she was red and said something to her. She was in her room for about an hour and noticed she was itching but ignored it given she was busy and in the ICU (intensive care unit). Around 08:15, she noticed hives on her chest and neck, and developed a dry cough, and some wheezing, and she took 50 of diphenhydramine. By 10am, she had two hives on left of her neck and chest, skin continued to be red. 11:40 she went to employee health and they took her vital signs. Blood pressure and pulse oximetry 130/80, and HR was 110. They told her she did not need temperature done but she disagreed and took her own temp and it was 100F. Her heart rate is normally 50-70, BP (blood pressure) runs low 90-110/60s normally. Event treatment: 50 of diphenhydramine. For relevant test results see appropriate report section. Reporter's assessment: Non serious. The health authority added additional term body temperature increased. VAERS ID: 609387.
Age: 43.0
Sex: F
Vaccine: FLU3
Symptoms: Urticaria, Wheezing
Clinical narrative: This health authority report was received from a Health Professional and concerns a 43 years old female patient. Weight: not provided, Height: not provided. The patient has a medical history of Mild asthma, Seasonal allergies, Migraines, Cervical neck disk herniation (from auto accident), Vitamin D deficiency, WPW (Wolff-Parkinson White syndrome) (with ablation), Mitral valve prolapse, Allergies to sulfa, COMPAZINE and Allergy to bee stings. Sulfa (Indication: -, Reaction: allergy) and COMPAZINE (Indication: -, Reaction: allergy). The patient had no current illness. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 06-Nov-2015 - unknown stop date, Batch no: U55606, Route of administration: Intradermal (medication error not explicitly reported), Dose: 0.5 ml. No additional drugs suspected. On 06-Nov-2015 at 7:15am, the patient felt hot, and her skin on her chest and neck were red. The patient was a nurse and was in a patient's room in an isolation gown. She thought she was hot and the patient noticed she was red and said something to her. She was in her room for about an hour and noticed she was itching but ignored it given she was busy and in the ICU (intensive care unit). Around 08:15, she noticed hives on her chest and neck, and developed a dry cough, and some wheezing, and she took 50 of diphenhydramine. By 10am, she had two hives on left of her neck and chest, skin continued to be red. 11:40 she went to employee health and they took her vital signs. Blood pressure and pulse oximetry 130/80, and HR was 110. They told her she did not need temperature done but she disagreed and took her own temp and it was 100F. Her heart rate is normally 50-70, BP (blood pressure) runs low 90-110/60s normally. Event treatment: 50 of diphenhydramine. For relevant test results see appropriate report section. Reporter's assessment: Non serious. The health authority added additional term body temperature increased. VAERS ID: 609387.
Age: 51.0
Sex: M
Vaccine: FLU3
Symptoms: Asthenia, Dizziness, Headache, Myalgia, Pyrexia
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a(n) Health Professional and concerns a(n) 51 year old male patient. The patient had no medical history and no illness at the time of vaccination. Suspect drug(s), timing and conditions surrounding the onset of reaction(s)/event(s): The patient received AFLURIA on 12-Nov-2015 - unknown stop date, Batch no: U59408, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Left arm (LA). Additional suspect drug(s): No additional drugs suspected. Reaction(s) /event(s) and outcome: On 12-Nov-2015, 1 day after starting / treatment with AFLURIA the patient experienced dizzy (non serious, outcome: Recovered / Resolved); weakness (non serious, outcome: Recovered / Resolved), Headache (non serious, outcome: Recovered / resolved), fever of 103 (non-serious, outcome: Recovered / resolved), Muscle aches (non serious, outcome: recovered / resolved). Lab data: None. Reporter's assessment: Non serious.
Age: 53.0
Sex: F
Vaccine: FLU3
Symptoms: Blister, Pain in extremity, Rash, Skin tightness
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a(n) Health Professional and concerns a(n) 53 year old female patient. Suspect drug(s), timing and conditions surrounding the onset of reaction(s)/event(s): The patient received AFLURIA on 15-Oct-2015 - unknown stop date, Batch no: U58007, Route of administration: Intramuscular, Dose: 0.5 ml. site: Left arm (LA). Additional suspect drug (s): No additional drugs suspected. Reaction(s) events(s) and outcome: On 16-Oct-2015, 2 days after starting / treatment with AFLURIA the patient experienced arm is sore (non serious, outcome: unknown), arm is tight feeling (non serious, outcome: unknown), blister (non serious, outcome: unknown), blistered rash on arm and body (non serious, outcome: unknown), rash (non serious, outcome: unknown). Reporter's assessment: Non serious. The health authority reported the symptoms: blister, rash.
Age: 56.0
Sex: M
Vaccine: FLU3
Symptoms: Eye pruritus, Eyelid oedema, Injection site swelling, Pruritus
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case reporter was received from a(n) Health Professional  and concerns a(n) 56 year old male patient. Suspect drug(s), timing and conditions surrounding the onset of reaction(s)/event(s): The patient received AFLURIA on 10-Nov-2015 - unknown stop date, Batch no: U54908, Route of administration: 'SYR', Dose: 0.5 ml, site: Left arm (LA). Additional suspect drug(s): No additional drugs suspected. Reaction(s) /event(s) and outcome: On 11-Nov-2015, 2 days after starting /treatment with AFLURIA the patient experienced eyes swollen shut (non serious, outcome: Recovered / Resolved). Eyes itchy (non serious, outcome: Recovered / Resolved, itching (non serious, outcome: Recovered / Resolved), swelling at injection site (non serious, outcome: Recovered / resolved). Reporter's assessment: Non-serious.
Age: 59.0
Sex: F
Vaccine: FLU3
Symptoms: Vertigo
Clinical narrative: The case report was received from a(n) Health Professional and concerns a(n) 59 year old female patient. The patient had no medical history and no illness at the time of vaccination. Suspect drug(s), timing and conditions surrounding the onset of reaction(s)/events (s): The patient received AFLURIA  on 11-Nov-2015 - unknown stop date, Batch no: U54906, route of administration: Intramuscular, Dose: 0.5 ml, Site: Left arm (LA). Additional suspect drug(s): No additional drugs suspected. On 12-Nov-2015, 2 days after starting / treatment with AFLURIA the patient experienced very had vertigo (non serious, outcome: unknown). Vertigo early morning lasting into the next day. Worse while changing sleep positions at night. Reporter's assessment: Non serious.
Age: 62.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Stomatitis
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a(n) Health Professional and concerns a(n) 62 year old male patient. The patient has a medical history of Diabetes, Increased cholesterol, and hypothyroid. The patient had no illness at the time of vaccination. The patient received AFLURIA on 23-Sep-2015, Batch no: U58608, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Unknown. Additional suspect drug: PNEUMOVAX (batch number: K009874), Site: Unknown. On 23-Sep-2015, 1 day after starting treatment with AFLURIA the patient experienced sores in his mouth. He did not seek medical treatment, but missed 1 day of work. Cleared up in a day or 2. Reporter's assessment: Non serious.
Age: 72.0
Sex: F
Vaccine: FLU3
Symptoms: Muscle disorder, Myalgia
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 72 years old female patient. The patient had no medical history and no illness at the time of vaccination. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 21-Oct-2015 - unknown stop date, Batch no: U58407, Route of administration: Intramuscular, Dose: 0.5 ml, Site; Left arm (LA). No additional drugs suspected. On 22-Oct-2015, 2 days after starting treatment with AFLURIA the patient experienced Limited use of shoulder muscle, Muscle soreness. Reporter's assessment: Non -serious. VAERS ID: 609673.
Age: 47.0
Sex: F
Vaccine: FLU3
Symptoms: Blepharospasm, Hypoaesthesia
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 47 years old female patient. Weight: not provided, Height: not provided. For concomitant medication and therapy dates refer to the appropriate report sections. The patient had no medical history or current illness. The patient received AFLURIA on 12-Nov-2015 - unknown stop date, Batch no: U57507, Route of administration: Intramuscular. Dose: 0.5 ml, Site: left arm. No additional drugs suspected. On 12-Nov-2015, 1 day after starting treatment with AFLURIA the patient experienced Facial numbness, Eye twitching. The events persisted for 8 hours (until he went to sleep) and resolved upon waking. No treatment necessary. For relevant test results see appropriate report section. Reporter's assessment: The health authority assessed the events as non-serious. VAERS ID: 609675.
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: Grip strength decreased, Hypoaesthesia, Injection site pain
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 46 year old female patient. The patient had no medical history and no illness at the time of vaccination. Concomitant medications at the time of vaccination are unknown. The patient received AFLURIA on 03-Oct-2015 - unknown stop date, Batch no: U56106, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Right arm (RA). No additional drugs suspected. On 08-Oct-2015, 6 days after starting / treatment with AFLURIA the patient experienced R arm numbness, R shoulder pain, R difficulty with grasp. It has slowly improved but the patient still has symptoms periodically (per MD note). The patient's PCP suggested a neurology evaluation and MD agreed (per MD note). Reporter's assessment: Non serious. VAERS ID: 609678.
Age: 52.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Peripheral swelling, Rash
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 52 year old male patient. The patient has a medical history of COPD. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 13-Nov-2015 - unknown stop date, Batch no: U59208, Route of administration, Intramuscular, Dose: 0.5 ml, Site: Right arm (RA). PNEUMOVAX, Batch no: L024129, Site: Left arm (LA). On 14-Nov-2015, 2 days after starting / treatment with AFLURIA the patient experienced Arm was swelling / It was his right arm where received the flu shot, Rash spread down to his elbow. The patient called in the morning to say his arm was swelling from the pneumonia vaccine at the time. However, his girlfriend called back in the afternoon and stated it was in his right arm which is where he received the flu shot. The patient was advised to go to the ER or urgent care. Reporter's assessment: Non serious. VAERS ID: 609685.
Age: 63.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site mass, Injection site swelling
Clinical narrative: This health authority case was initially received on 22-Jan-2016. The case report was received from a Health Professional and concerns a 63 years old female patient. Weight: not provided, Height: not provided. For concomitant medication and therapy dates refer to the appropriate report sections. The patient had no current illness. The patient received AFLURIA on 15-Nov-2015 - unknown stop date, Batch no: U58808, Route of administration: Intramuscular, Dose: 0.5 ml, Site: left arm. No additional drugs suspected. On 15-Nov-2015, after starting / treatment with AFLURIA the patient experienced Some swelling at deltoid injection site, Lump at deltoid injection site. The patient had no difficulty breathing or other side effects in 25-30 minutes of monitoring. For relevant test results see appropriate report section. Reporter's assessment: Non serious. VAERS ID: 609709.
Age: 29.0
Sex: M
Vaccine: FLU3, VARCEL
Symptoms: Injection site pain, Rash
Clinical narrative: This health authority case was initially received on 22-Jan-2016. The case report was received from a(n) Health Professional and concerns a(n) 29 years old male patient. Weight: not provided, Height: not provided. The patient had no reported medical history and no current illness. The patient received AFLURIA on 15-Nov-2015, Batch no: U56106, Route of administration: Intramuscular, Dose: 0.5 ml, Site: left arm. On the same day the patient also received VARIVAX (batch no: L017997) in the left arm. Both vaccines were administered in the left arm. On 15-Nov-2015, 1 day after starting treatment with AFLURIA the patient experienced rash on shoulder, torso and neck, and a sore arm at injection site. Reporter's assessment: Non serious.
Age: 42.0
Sex: M
Vaccine: FLU3
Symptoms: Pain in extremity
Clinical narrative: This health authority case was initially received on 22-Jan-2016. The case report was received from a Health Professional and concerns a 42 years old male patient. Weight: not provided, Height: not provided. The patient had no listed history, current illness or medications at time of vaccination. The patient received AFLURIA on 04-Nov-2015 - unknown stop date, Batch no: U50609, Route of administration: Intramuscular, Dose: 0.5 ml, Site: right arm. No additional drugs suspected. On an unknown date, 2 days after starting / treatment with AFLURIA the patient experienced Pain in the arm that got the vaccine. It continued for more than 3-4 days. The patient visited the family MD (medical doctor). Reporter's assessment: Non serious. VAERS ID: 609921.
Age: 64.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain
Clinical narrative: This health authority case was initially received on 22-Jan-2016. The case report was received from a(n) Health Professional and concerns a(n) 64 years old female patient. Weight: not provided, Height: not provided. The patient had no medical history or current illness. The patient received AFLURIA on 09-Sep-2015, Batch no: U55406, Route of administration: Intramuscular, Dose: 0.5 ml, Site: left arm. No additional drugs suspected. On 09-Sep-2015, after starting treatment with AFLURIA the patient experienced pain occurring during injections. Pain did not subside after. Reporter's assessment: Non serious.
Age: 53.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site pain, Injection site reaction, Muscle twitching
Clinical narrative: This health authority case was initially received on 22-Jan-2016. The case report was received from a Health Professional and concerns a 53 years old male patient. Weight: not provided, Height: not provided. The patient had no medical history or current illness. The patient received AFLURIA on 23-Oct-2015 - unknown stop date, Batch no: U66906, Route of administration: Intramuscular, Dose: 0.5 ml, Site: right arm. No additional drugs suspected. On 23-Oct-2015, 1 day after starting / treatment with AFLURIA the patient experienced once in a while Muscle twitching at the injection site, Shock like pain (at the injection site), Injection site reaction. The pain comes and goes. Reporter's assessment: Non serious.  VAERS ID: 609945.
Age: 33.0
Sex: M
Vaccine: FLU3
Symptoms: Chest pain, Chills, Muscle spasms, Pyrexia
Clinical narrative: This health authority case was initially received on 22-Jan-2016. The case report was received from a(n) Health Professional and concerns a(n) 33 years old male patient. Weight: not provided, Height: not provided. The patient had not medical history or current illness. The patient received AFLURIA on 06-Nov-2015, Batch no: U57307, Route of administration: Intramuscular, Dose: 0.5 ml, Site: left arm. No additional drugs suspected. On 06-Nov-2015, 1 day after starting treatment with AFLURIA the patient experienced chest pains, leg cramp, shivering, and low grade fever. Reporter's assessment: Non serious.
Age: 50.0
Sex: F
Vaccine: FLU3
Symptoms: Drug administered at inappropriate site, Injection site pain, Musculoskeletal pain, X-ray
Clinical narrative: This health authority case was initially received on 22-Jan-2016. The case report was received from a Health Professional and concerns a 50 years old female patient. Weight: not provided, Height: not provided. The patient has a medical history of Hypertension. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 09-Oct-2015 - unknown stop date, Batch no: U56907, Route of administration: Intramuscular, Dose; 0.5 ml. Site: left arm. No additional drugs suspected. On 09-Oct-2015, after starting / treatment with AFLURIA the patient experienced Shoulder pain, she was given a flu shot right near shoulder joint which was above the deltoid muscle on left arm, Injection site pain. Event after 3-4 weeks, the patient was complaining about shoulder pain. X-ray was done the week of 16-Nov-2015 and specialist visit on the week of 22-Nov-2015. Reporter's assessment: Non serious. VAERS ID: 610265.
Age: 30.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain
Clinical narrative: This health authority case was initially received on 22-Jan-2016. The case report was received from a Health Professional and concerns a 30 years old female patient. Weight: not provided, Height: not provided. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 13-Oct-2015 - unknown stop date, Batch no: U59408, Route of administration: not provided, Dose: 0.5 ml, Site: left arm. No additional drugs suspected. On 14-Oct-2015, 2 days after starting / treatment with AFLURIA the patient experienced Prolonged pain at the injection site, lasting roughly 3 weeks post admin. No other symptoms present. It was suggested the patient go to PCP (primary care physician). Reporter's assessment: Non serious. VAERS ID: 610318.
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Chills, Headache, Ocular hyperaemia, Palpitations, Throat tightness
Clinical narrative: This health authority case was initially received on 22-Jan-2016. the case report was received from a(n) Health Professional and concerns a(n) 57 years old female patient. Weight: not provided, Height: not provided. The following drug history information was reported: Smallpox, Reaction: adverse event. The patient had no medical history, current illness or medications at time of vaccination. The patient received AFLURIA on 18-Nov-2015, Batch no: 11949211A, Route of administration: Intramuscular, Dose: Site: right arm. No additional drugs suspected. On 18-Nov-2015, 1 day after starting treatment with AFLURIA the patient experienced throat tightness, eyes bloodshot, headache, chills, and palpitations. Reporter's assessment: Non serious.
Age: 45.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain
Clinical narrative: This health authority case was initially received on 22-Jan-2016. The case report was received from a Health Professional and concerns a 45 years old female patient. Weight: not provided, Height: not provided. The patient has a medical history of Sinus allergy. The patient had no current illness. The patient received AFLURIA on 07-Oct 2015 - unknown stop date, Batch no: U54906, Route of administration: Unknown, Dose: 0.5 ml, Site: left arm. No additional drugs suspected. On 14-Oct-2015, 1 week 1 day after starting treatment with AFLURIA the patient experienced Pain in left shoulder (that radiates into bicep), (Pain in left shoulder) that radiates into bicep, Injection site pain. The health authority added additional term injection site pain. VAERS ID: 610602.
Age: 37.0
Sex: F
Vaccine: FLU3
Symptoms: Eye swelling, Lip swelling, Ocular hyperaemia
Clinical narrative: This health authority case was initially received on 22-Jan-2016. The case report was received from a Health Professional and concerns a 37 years old female patient. Weight: not provided, Height: not provided. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 17-Nov-2015 - unknown stop date, Batch no: U50509, Route of administration: Intramuscular, Dose: 0.5 ml, Site: left arm. No additional drugs suspected. On 18-Nov-2015, in the morning she woke up and experienced Swollen lips, Swollen eyes, Red eyes. Took diphenhydramine and felt better. Reporter's assessment: Non serious. VAERS ID: 610714.
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Joint range of motion decreased
Clinical narrative: This health authority case was initially received on 22-Jan-2016. The case report was received from a(n) Health Professional and concerns a(n) 57 years old female patient. Weight: not provided, Height: not provided. The patient had no medical history or current illness. The patient received AFLURIA on 25-Oct-2015, Batch no: 11049211A, Route of administration: Intramuscular, Dose: no information provided. No additional drugs suspected. On 25-Oct-2015, 1 day after treatment with AFLURIA the patient experienced limited range of movement on arm even after two and a half weeks. Reporter's assessment: Non serious.
Age: 69.0
Sex: M
Vaccine: FLU3
Symptoms: Fatigue, Headache, Pain
Clinical narrative: This health authority case was initially received on 22-Jan-2016. The case report was received from a Health Professional and concerns a 69 years old male patient. Weight: not provided, Height: not provided. The patient has a medical history of sulfa, tetracycline, erythromycin (allergy), Heart disease, COPD, Emphysema and Eczema. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 16-Nov-2015 - unknown stop date, Batch no: not provided, Route of administration: Intramuscular, Dose: Site: left arm. No additional drugs suspected. On 18-Nov-2015, 3 days after starting / treatment with AFLURIA the patient experienced Exhaustion, Headache, Body aches. The patient had no fever and no treatment. Reporter's assessment: Non serious. VAERS ID: 610792.
Age: 53.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site mass, Injection site reaction, Muscle fatigue
Clinical narrative: This health authority case was initially received on 22-Jan-2016. The case report was received from a(n) Health Professional and concerns a(n) 53 years old female patient. Weight: not provided, Height: not provided. The patient had no medical history or current illness. The patient received AFLURIA on 24-Sep-2015, Batch no: not provided, Route of administration: Intramuscular, Dose: Site: left arm. No additional drugs suspected. On 24-Sep-2015, 1 day after starting treatment with AFLURIA the patient experienced muscle fatigue at the inject site, and lump at the injection site. Reporter's assessment: Non serious.
Age: 32.0
Sex: F
Vaccine: FLU3
Symptoms: Dyspnoea
Clinical narrative: This health authority case was initially received on 22-Jan-2016. The case report was received from a Health Professional and concerns a 32 years old female patient. Weight: not provided, Height: not provided. For concomitant medication and therapy dates refer to the appropriate report sections. The patient had no medical history or current illness. The patient received AFLURIA on 19-Nov-2015 - unknown stop date, Batch no: U56807, Route of administration: Intramuscular, Dose: 0.5 ml, Site: right arm. No additional drugs suspected. On 19-Nov-2015 16:15, after starting / treatment with AFLURIA the patient experienced Shortness of breath. The patient was given 50 mg of diphenhydramine and one dose of adrenaline 0.3 mg IM (intramuscular). Paramedics were called and arrived within about 5 minutes, the patient was taken to hospital for observation. For relevant test results see appropriate report section. Reporter's assessment: Non serious. VAERS ID: 610837.
Age: 49.0
Sex: F
Vaccine: FLU3, PNC13, TDAP
Symptoms: Injection site hypoaesthesia, Injection site pain, Injection site paraesthesia, Injection site reaction
Clinical narrative: This health authority case was initially received on 22-Jan-2016. Follow up information received on 22-Jan-2016. The case report was received from a(n) Health Professional and concerns a(n) 40 years old female patient. Weight: not provided, Height: not provided. The patient had no current illness or medical history. The patient received AFLURIA on 02-Oct-2015, Batch no: U55706, Route of administration: Intramuscular, Dose: 0.5 ml, Site: left arm. On the same day, the patient also received PREVNAR 13 (batch no: L77777) via intramuscular route in the right arm, and BOOSTRIX (batch no: E735A) via intramuscular route in the right arm. On 20-Oct-2015, 2 weeks 5 days after starting treatment with AFLURIA the patient experienced periodic numbness, pain in left upper arm, tingling in left upper arm, and injection site reaction. Reporter's assessment: Non serious. The health authority coded addition preferred term injection site reaction.